Авторы

  • Eshankulova N.Y., Azizova R.B.

Ключевые слова:

alpha-synuclein, essential tremor, biomarker, Parkinson’s disease, exosome, ELISA, neurodegeneration.

Библиографические ссылки

Albillos, A., García-Martín, E., & Núñez, Á. Alpha-synuclein levels in Parkinson’s disease and essential tremor: A comparative analysis. //Movement Disorders. -2021. -№ 36(4).-Р. -701–710.

Alfaidi, M., Barker, R. A., & Kuan, W.-L.. An update on immune-based alpha-synuclein trials in Parkinson’s disease. // Journal of Neurology, 2024. -№ 272(1). –Р. 21–33.

Bhatia, K. P., Bain, P., Bajaj, N., Elble, R. J., Hallett, M., Louis, E. D., … Deuschl, G. Consensus statement on the classification of tremors. //Movement Disorders, 2018. -№33(1). –Р. -75–87.

Bhidayasiri, R., Cardoso, F., LeWitt, P. A., & Hallett, M.. The International Parkinson and Movement Disorder Society evidence-based medicine review update: Treatments for essential tremor. //Movement Disorders, 2022. -№ 37(2). –Р. -249–267.

Bloomer, R. J. Effect of exercise on oxidative stress biomarkers. // Advances in Clinical Chemistry, 2018. -№ 46. –Р. -1–50.

Xi, H., Tian, J., Chen, Y., Yan, Y., Pu, J., & Zhang, B. Central nervous system-derived exosomal alpha-synuclein in serum may be a biomarker in Parkinson's disease. // Neuroscience Letters, 2019. -№724. –Р. -166–170.

Faust, P. L. Is essential tremor a degenerative disorder or an electric disorder? // International Review of Neurobiology, 2022.-№163.-Р.-65–101.

Feigin, V. L., Vos, T., Alahdab, F., et al. Global burden of neurological disorders: A systematic analysis for the Global Burden of Disease Study 2021.// The Lancet Neurology, 2023. -№ 22(1).-Р. -30–55.